COMMUNIQUÉS West-GlobeNewswire

Fulgent Genetics to Announce Third Quarter 2018 Financial Results on Tuesday November 6, 2018
23/10/2018
TEMPLE CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2018 financial results after the [...]
Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics' Lead Drug Candidate VB-111 until October 2033
23/10/2018
TEL AVIV, Israel, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced the issuance by the European Patent Office (EPO) of Patent No. 2908865, a composition of matter patent which covers VB- [...]
Healthwise Announces Dr. Adam Husney as CEO
23/10/2018
The Healthwise board of directors today named Dr. Adam Husney to be the next Healthwise CEO effective immediately BOISE, Idaho, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, [...]
Milestone Scientific Signs U.S. Distribution Agreement for the CompuFlo® Epidural System with Medical Device Distributor Clinical Technology, Inc.
23/10/2018
New distribution agreement follows successful trials with top anesthesiologists LIVINGSTON, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS ), a developer of computerized drug delivery [...]
BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018
23/10/2018
RALEIGH, N.C., Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living with chronic [...]
Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
23/10/2018
Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options Development Strategy Leverages Neos’ Modified-Release Microparticle, Drug [...]
Leading Ophthalmologists to Discuss the Value of IRIDEX Solutions at AAO
23/10/2018
Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® Technology MOUNTAIN VIEW, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX), a leading provider of innovative laser [...]
Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications
23/10/2018
Mobile Wireless Monitoring Solution with High Fidelity Metrics Could Make Non-Invasive Maternal/Fetal Monitoring a Reality REDWOOD CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a [...]
Alder BioPharmaceuticals® Announces Positive Results From Pharmacokinetic Comparability Study for Eptinezumab
23/10/2018
BOTHELL, Wash., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Inovalon Clients Realize Significant Increases in CMS Star Ratings Compared to National Average For 5th Year In a Row
23/10/2018
Advanced Analytics and Data-Driven Capabilities Powered by the Inovalon ONE® Platform Support Meaningful Quality Outcomes Improvements BOWIE, Md., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading [...]
Arvinas to Present at Two Protein Degradation Conferences
23/10/2018
NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced it will be presenting at two upcoming [...]
Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results
23/10/2018
Call to be held on Monday, October 29th at 4:30 p.m. Eastern Time AUSTIN, Texas, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, announced today it will release [...]
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
23/10/2018
NORTHVALE, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Canada House Wellness Group Will Hold Annual General Meeting on October 30th
23/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) would like to [...]
KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications
23/10/2018
Drug Development Approach Combines twoXAR’s Artificial-Intelligence-Driven Drug Discovery Technology with KemPharm’s LAT TM Prodrug Technology CORALVILLE, Iowa, Oct. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: [...]
Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018
23/10/2018
Interim analysis indicates serum uric acid (SUA) control has been maintained into months four and five with once monthly combination treatment, SUA control projected to be 66% at end of study period Patient imaging has [...]
IMV Inc. to Announce Third Quarter 2018 Financial Results and Host Earnings Call on November 2, 2018
23/10/2018
DARTMOUTH, Nova Scotia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical stage immunotherapy company, announced today that it will hold a conference call and [...]
Myriad Announces Publication of Foresight™ Carrier Screen Clinical Utility Study in Genetics in Medicine
23/10/2018
Large Study Demonstrates that Expanded Carrier Screening Informs Couples’ Reproductive Choices and Pregnancy Management SALT LAKE CITY, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global [...]
Resonant Releases Details of its Breakthrough XBAR Resonator Technology for 5G Mobile Devices
23/10/2018
GOLETA, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, today released [...]

Pages